Seyedmohammad Saadatagah, MD; Mohammadreza Naderian, MD, MPH; Mesbah Uddin, MSc, PhD; et al.
JAMA Cardiol. 2024;9(6):497-506. doi:10.1001/jamacardio.2024.0459
This cohort study investigates the association of clonal hematopoiesis of indeterminate potential with risk for atrial fibrillation.
Ravi B. Patel, MD, MSc; Frank E. Silvestry, MD; Jan Komtebedde, DVM; et al.
has audio
JAMA Cardiol. 2024;9(6):507-522. doi:10.1001/jamacardio.2024.0520
This post hoc analysis of A Study to Evaluate the Corvia Medical Inc IASD System II to Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF II) randomized clinical trial evaluates the long-term effects of an atrial shunt device on cardiac structure and function in patients with heart failure and preserved or mildly reduced ejection fraction.
-
Podcast:
Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction
Yi Li, MD; Jing Li, MD; Bin Wang, MD; et al.
JAMA Cardiol. 2024;9(6):523-531. doi:10.1001/jamacardio.2024.0534
This randomized clinical trial evaluates clopidogrel monotherapy vs dual antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions who are at high bleeding and ischemic risk.
-
Invited Commentary
Clopidogrel Monotherapy for Double-Risk Acute Coronary Syndrome
Marco Valgimigli, MD, PhD; Antonio Landi, MD
JAMA Cardiol
AI in Cardiology
Evangelos K. Oikonomou, MD, DPhil; Gregory Holste, BA; Neal Yuan, MD; et al.
JAMA Cardiol. 2024;9(6):534-544. doi:10.1001/jamacardio.2024.0595
This cohort study explores whether a novel artificial intelligence (AI) video-based biomarker for aortic stenosis is associated with development and progression of aortic stenosis.
Alireza Oraii, MD; William F. McIntyre, MD, PhD; Ratika Parkash, MD, MSc; et al.
JAMA Cardiol. 2024;9(6):545-555. doi:10.1001/jamacardio.2024.0675
This systematic review and meta-analysis investigates the efficacy of catheter ablation compared with rate or rhythm control among patients with atrial fibrillation and heart failure.
-
Editor's Note
Atrial Fibrillation Ablation in Heart Failure鈥擬ore Data Are Needed
Kristen K. Patton, MD; Clyde W. Yancy, MD, MSc
JAMA Cardiol
AI in Cardiology
Zhuo Chen, PhD; Jean-Eudes Dazard, PhD; Yassin Khalifa, PhD; et al.
free access
JAMA Cardiol. 2024;9(6):556-564. doi:10.1001/jamacardio.2024.0749
This cross-sectional study investigates the association between cardiometabolic disease prevalence in the US and deep learning鈥揵ased assessment of the built environment from satellite imagery.
Andrea Erriquez, MD; Gianluca Campo, MD; Vincenzo Guiducci, MD; et al.
JAMA Cardiol. 2024;9(6):565-573. doi:10.1001/jamacardio.2024.0804
This randomized clinical trial investigates if patients with high bleeding risk and a history of myocardial infarction (MI) would benefit from complete vs culprit-only revascularization.